CTRI/2024/06/069377尚未招募Unknown
Androgen receptor in breast cancer - clinical and prognostic outcomes - Nil
il0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patient undergoing surgery for breast cancer and specimen sent for IHC.
- •Patient who underwent trucut and sent for IHC.
- •All patients received treatment at KMC both for metastatic and non metastatic breast cancer.
- •Patients consenting to be part of study.
- •Patients above 18 years of age.
排除标准
- •Age below 18 years.
- •Patient not willing to participate in study.
- •Male breast carcinoma.
- •Other malignancy at the time of breast cancer diagnosis.
- •Prior chemotherapy.
- •Patient failing tofollow up.
研究者
相似试验
已完成
2 期
AR and ER Imaging in Metastatic Breast CancerMetastatic Breast CancerNCT01988324University Medical Center Groningen24
招募中
不适用
Exploring the role of androgen receptor blockade in increasing the expression of prostate specific membrane antigen (PSMA) and enhancing 68Ga-PSMA-11-PET/CT imaging in patients with metastatic prostate cancerCancer - ProstateProstate CancerACTRN12619000720112GenesisCare40
已完成
3 期
HABITSHormonal replacement therapy after breast cancer diagnosis - is it safe?Breast CancerACTRN12607000038493Regional Oncologic Centre, Sweden1,300
终止
2 期
Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast CancerMetastatic Breast CancerNCT00303615Legacy Health System5
已完成
2 期
Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)Metastatic Breast CancerNCT01990209SCRI Development Innovations, LLC71